EPA's ToxCast TM program evaluated the developmental toxicity risk of 1,065 compounds using Stemina Biomarker Discovery's human cell-based devTOX quickPredict test (devTOXqP). Agency scientists found that the devTOXqP platform predicted the potential for human developmental toxicity with an accuracy of 82%, where there was clear evidence of toxicity in humans or in animal studies. This suggests that devTOXqP is a useful tool for predicting developmental toxicants in humans and reducing the need for animal testing.
Cell-based test shows potential to predict which drugs and chemicals cause birth defects
- 3. 3 2020 (06:00)